<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T08:50:22Z</responseDate>
  <request identifier="oai:figshare.com:article/33972937" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33972937</identifier>
        <datestamp>2026-09-23T11:40:00Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_135</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_2</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Structural Insights into the β‑Clasp
and Dimerization Interface of Human Ribokinase</dc:title>
          <dc:creator>Juliana
C. Ferreira (25096993)</dc:creator>
          <dc:creator>Adrian J. Villanueva (25096996)</dc:creator>
          <dc:creator>Samar Fadl (22909779)</dc:creator>
          <dc:creator>Zhandos Shegenov (25096999)</dc:creator>
          <dc:creator>Zeynep Nur Cinviz (25097002)</dc:creator>
          <dc:creator>Ozge Sensoy (1959838)</dc:creator>
          <dc:creator>Wael M. Rabeh (1850482)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Computational  Biology</dc:subject>
          <dc:subject>productive phosphoryl transfer</dc:subject>
          <dc:subject>predominantly monomeric variants</dc:subject>
          <dc:subject>potential allosteric target</dc:subject>
          <dc:subject>human ribokinase ribokinase</dc:subject>
          <dc:subject>catalysis remains unclear</dc:subject>
          <dc:subject>bond networkthat forms</dc:subject>
          <dc:subject>integrated functional analyses</dc:subject>
          <dc:subject>clasp using structure</dc:subject>
          <dc:subject>core dimer scaffold</dc:subject>
          <dc:subject>reduced ribose retention</dc:subject>
          <dc:subject>clasp dimerization motif</dc:subject>
          <dc:subject>human rk stability</dc:subject>
          <dc:subject>β ‑ clasp</dc:subject>
          <dc:subject>thermal stability</dc:subject>
          <dc:subject>functional role</dc:subject>
          <dc:subject>clasp flexibility</dc:subject>
          <dc:subject>preserving dimerization</dc:subject>
          <dc:subject>yielding inactive</dc:subject>
          <dc:subject>type activity</dc:subject>
          <dc:subject>surrounding network</dc:subject>
          <dc:subject>substrate recognition</dc:subject>
          <dc:subject>substrate affinity</dc:subject>
          <dc:subject>step essential</dc:subject>
          <dc:subject>rk ),</dc:subject>
          <dc:subject>quantitative contribution</dc:subject>
          <dc:subject>phosphofructokinase b</dc:subject>
          <dc:subject>nucleotide biosynthesis</dc:subject>
          <dc:subject>minimal effects</dc:subject>
          <dc:subject>lid positioning</dc:subject>
          <dc:subject>largely tolerated</dc:subject>
          <dc:subject>ischemic injury</dc:subject>
          <dc:subject>hydrophobic interactions</dc:subject>
          <dc:subject>guided mutagenesis</dc:subject>
          <dc:subject>graded manner</dc:subject>
          <dc:subject>findings identify</dc:subject>
          <dc:subject>energy metabolism</dc:subject>
          <dc:subject>dimerization interface</dc:subject>
          <dc:subject>dependent phosphorylation</dc:subject>
          <dc:subject>conserved feature</dc:subject>
          <dc:subject>cell proliferation</dc:subject>
          <dc:subject>binding network</dc:subject>
          <dc:subject>although far</dc:subject>
          <dc:description>Ribokinase (RK),
a member of the phosphofructokinase B (PfkB) family,
catalyzes the ATP-dependent phosphorylation of d-ribose to
ribose-5-phosphate, a step essential for nucleotide biosynthesis and
pentose phosphate pathway flux. Because these pathways support redox
balance, energy metabolism, and cell proliferation, RK is relevant
to cancer and ischemic injury. A conserved feature of PfkB enzymes
is the β-clasp dimerization motif, an interlocking β-strand
interface between protomers. However, its quantitative contribution
to human RK stability and catalysis remains unclear. Here, we define
the structural and functional role of the RK β-clasp using structure-guided
mutagenesis and integrated functional analyses. The β-clasp
contains two interaction layers: (1) a β3a–β7 backbone
hydrogen-bond networkthat forms the core dimer scaffold and (2) a
surrounding network of polar and hydrophobic interactions that reinforce
the interface. Alanine substitutions disrupting individual polar interactions
were largely tolerated, preserving dimerization, near-wild-type activity,
and thermal stability. However, disruption of the V122/V124-centered
hydrophobic core reduced catalytic turnover with minimal effects on
substrate affinity, indicating that the β-clasp primarily supports
catalytic competence rather than substrate recognition. Progressive
β3a deletions destabilized the dimer in a graded manner, yielding
inactive, predominantly monomeric variants with noncooperative biphasic
thermal unfolding transitions, although far-UV circular dichroism
confirmed retention of the α/β fold. Molecular dynamics
simulations showed that disruptive variants increased β-clasp
flexibility, weakened the Asp27-centered ribose-binding network, and
reduced ribose retention. Together, these findings identify the β-clasp
as a conformational hub coupling dimerization to lid positioning and
productive phosphoryl transfer, establishing it as a potential allosteric
target for regulation.</dc:description>
          <dc:date>2026-09-23T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Media</dc:type>
          <dc:identifier>10.1021/acs.biochem.6c00373.s002</dc:identifier>
          <dc:relation>https://figshare.com/articles/media/Structural_Insights_into_the_Clasp_and_Dimerization_Interface_of_Human_Ribokinase/33972937</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
